Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 11:06:03 UTC |
---|
Update Date | 2021-09-26 23:05:53 UTC |
---|
HMDB ID | HMDB0252950 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide |
---|
Description | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide belongs to the class of organic compounds known as pyridinylpiperazines. Pyridinylpiperazines are compounds containing a pyridinylpiperazine skeleton, which consists of a pyridine linked (not fused) to a piperazine by a bond by a single bond that is not part of a ring. Based on a literature review very few articles have been published on (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). (s)-1-(sec-butyl)-n-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1h-indole-4-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC(C)N1C=C(C)C2=C(C=C(C=C12)C1=CN=C(C=C1)N1CCNCC1)C(=O)NCC1=C(C)C=C(C)NC1=O InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39) |
---|
Synonyms | Value | Source |
---|
1-(Butan-2-yl)-N-[(2-hydroxy-4,6-dimethylpyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indole-4-carboximidate | HMDB |
|
---|
Chemical Formula | C31H38N6O2 |
---|
Average Molecular Weight | 526.685 |
---|
Monoisotopic Molecular Weight | 526.305624488 |
---|
IUPAC Name | 1-(butan-2-yl)-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indole-4-carboxamide |
---|
Traditional Name | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1-(sec-butyl)indole-4-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC(C)N1C=C(C)C2=C(C=C(C=C12)C1=CN=C(C=C1)N1CCNCC1)C(=O)NCC1=C(C)C=C(C)NC1=O |
---|
InChI Identifier | InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39) |
---|
InChI Key | FKSFKBQGSFSOSM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyridinylpiperazines. Pyridinylpiperazines are compounds containing a pyridinylpiperazine skeleton, which consists of a pyridine linked (not fused) to a piperazine by a bond by a single bond that is not part of a ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | Pyridinylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - Pyridinylpiperazine
- N-arylpiperazine
- 3-methylindole
- N-alkylindole
- 3-alkylindole
- Indole
- Indole or derivatives
- Dialkylarylamine
- Hydroxypyridine
- Aminopyridine
- Methylpyridine
- Imidolactam
- Pyridine
- Benzenoid
- Substituted pyrrole
- Heteroaromatic compound
- Pyrrole
- Azacycle
- Carboximidic acid
- Carboximidic acid derivative
- Secondary aliphatic amine
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Secondary amine
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M-2H]- | 253.561 | 30932474 | DeepCCS | [M+Na]+ | 228.986 | 30932474 |
Predicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Predicted by Siyang on May 30, 2022 | 10.7327 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.83 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1035.0 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 131.3 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 195.3 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 143.0 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 96.1 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 396.6 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 365.9 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 452.6 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 759.3 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 370.6 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1384.8 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.0 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 332.7 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 361.0 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 366.3 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 15.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)[NH]C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 5086.8 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)[NH]C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 4885.4 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)[NH]C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 6003.7 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4856.1 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4660.3 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5966.2 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4998.1 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4680.1 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5966.5 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 4911.3 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 4917.6 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 5744.8 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 5057.2 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 4941.3 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 5745.6 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4814.4 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4722.5 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5674.5 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,3TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 4883.8 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,3TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 4963.6 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,3TMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C)C3=O)[Si](C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C)CC4)N=C3)C=C21 | 5517.0 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)[NH]C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5327.2 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)[NH]C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5042.5 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)[NH]C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 6067.3 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5054.9 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4849.8 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5954.1 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5184.7 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 4891.6 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,1TBDMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5925.4 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5275.6 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5264.0 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)[NH]C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5801.3 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5453.2 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5292.2 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #2 | CCC(C)N1C=C(C)C2=C(C(=O)NCC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5775.1 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5180.7 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5123.6 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,2TBDMS,isomer #3 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCNCC4)N=C3)C=C21 | 5654.3 | Standard polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,3TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5418.4 | Semi standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,3TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5490.8 | Standard non polar | 33892256 | (S)-1-(Sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,3TBDMS,isomer #1 | CCC(C)N1C=C(C)C2=C(C(=O)N(CC3=C(C)C=C(C)N([Si](C)(C)C(C)(C)C)C3=O)[Si](C)(C)C(C)(C)C)C=C(C3=CC=C(N4CCN([Si](C)(C)C(C)(C)C)CC4)N=C3)C=C21 | 5588.0 | Standard polar | 33892256 |
|
---|